Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1136/rmdopen-2020-001235
Published Online: 2021-02-17
Published Print: 2021-02
Update policy: https://doi.org/10.1136/crossmarkpolicy
Riley, Thomas R
George, Michael D https://orcid.org/0000-0002-0398-2308
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23-AR073931-01)
License valid from 2021-02-17